scorecardresearchPfizer Share Price Live NSE, BSE, Today - Pfizer Stock Price
Mintgenie
Asian Paints3,143.507.20 (0.23%)
Axis Bank937.608.40 (0.90%)
Bajaj Finance7,003.1070.80 (1.02%)
Bajaj Finserve1,465.2515.60 (1.08%)
Bharti Airtel819.45-1.85 (-0.23%)
HCL Technologies1,135.709.50 (0.84%)
HDFC Bank1,637.052.20 (0.13%)
Hindustan Unilever2,656.106.00 (0.23%)
Housing Development Finance Corporation2,692.952.20 (0.08%)
ICICI Bank952.054.20 (0.44%)
ITC449.753.40 (0.76%)
Indusind Bank1,294.8010.15 (0.79%)
Infosys1,322.908.60 (0.65%)
Kotak Mahindra Bank1,973.5520.65 (1.06%)
Larsen & Toubro2,210.30-13.60 (-0.61%)
Mahindra & Mahindra1,328.20-1.25 (-0.09%)
Maruti Suzuki India9,397.0063.05 (0.68%)
NTPC176.700.65 (0.37%)
Nestle India21,568.00-152.95 (-0.70%)
Power Grid Corporation Of India235.200.65 (0.28%)
Reliance Industries2,519.40-0.40 (-0.02%)
State Bank Of India592.85-2.10 (-0.35%)
Sun Pharmaceutical Industries959.20-8.90 (-0.92%)
Tata Consultancy Services3,314.80-4.65 (-0.14%)
Tata Motors518.80-2.45 (-0.47%)
Tata Steel107.15-1.25 (-1.15%)
Tech Mahindra1,099.10-14.15 (-1.27%)
Titan Company2,799.20-10.85 (-0.39%)
Ultratech Cement7,895.0055.80 (0.71%)
Wipro402.502.90 (0.73%)

Pfizer

BSE: 500680 | NSE: PFIZER | ISIN: INE182A01018 | SECTOR: Major Drugs

₹3,796.90 -10.25 (-0.27%)

30 May 2023, 09:58 (IST)

  • Open

    3,830.00

  • High

    3,830.00

  • Low

    3,780.15

  • Prev Close

    3,807.15

  • P/E

    -

  • Median P/E

    -

  • P/B

    -

  • Median P/B

    -

  • Market Cap

    173.70B

  • Volume

    1.27K

  • Vol. (20 day Avg.)

    0

  • PEG

    -

  • Div.Yield

    -

  • Bid

    -

  • Ask

    -
View all metrics

Company Description

  • Major Drugs

  • BSE

    500680

  • NSE

    PFIZER

  • ISIN

    INE182A01018

Pfizer Limited is an India-based pharmaceutical company. The Company has a portfolio of approximately 150 products across over 15 therapeutic areas. The Company is engaged in manufacturing, marketing, trading and exporting pharmaceutical products. The Company offers a range of products for anti-diabetic, anti-infectives, cardiovascular, dermatology, erectile dysfunction, gastrointestinal (GI), multivitamins, neurology, pain/fever/inflammation and autoimmune disorders, among others. Its products include Trulimax, Vibazime DT, Viagra, Daxid, Tricorex, Mucaine, Diamox, Hetrazan, Enbrel, Ativan, Pacitane, Folvite Tablets, Autrin Capsules, Prevenar 13, Wysolone, Loette, Ovral G, Ovral L, Premarin tablets, Premarin Vaginal Cream, Zosyn, Wymox, Tygacil, Cynomycin, Targit, Cyklokapron and Magnamycin. The Company has its own manufacturing facility at Thane and Goa. The Company has various independent contract/third party manufacturers based across the country.

Company Officers

  • Milind Patil

    Executive Director - Finance, Chief Financial Officer

  • Meenakshi Nevatia

    Managing Director, Additional Executive Director

  • Samir Kazi

    Executive Director - Legal

  • Shilpi Singh

    Director - People Experience

  • Satyen Amin

    Director - Commercial Channel and Market Access

  • Sonali Dighe

    Senior Director - Medical Affairs

  • Sharad Goswami

    Senior Director - Policy and Public Affairs

  • Manish Mishra

    Category Lead - Inflammation and Immunology

  • Manish Paliwal

    Director - Regulatory Affairs

  • Anil Pattanshetty

    Senior Director - Commercial Operations